50 Key Biopharmaceutical and Biotechnology Companies

 
   Single User - $2,500
   Site License (one location, 10 users) - $3,750
   Corporate License - $5,000


Loading...
Published Dec 12, 2017 | 201 Pages | Pub ID: KLI15550511

50 Key Biopharmaceutical and Biotechnology Companies

50 Key Biopharmaceutical and Biotechnology Companies is a comprehensive look at the top 50 companies that are shaping the biotherapeutics market in 2017 and beyond. The top 50 companies in this report were chosen for a variety of reasons, including sales of marketed biopharmaceutical products, innovation in biotherapeutics, and unique additions to the market, either marketed products or products in development.

50 Key Biopharmaceutical and Biotechnology Companies
includes large traditional pharma powerhouses such as Pfizer, Novartis, Roche, Merck, GSK, Bristol-Myers Squibb, Bayer, and others; but it also includes smaller niche companies such as Genmab, Seattle Genetics, etc. In addition, it includes leading biopharmaceuticals such as Amgen and Biogen, and leading biotech companies such as Qiagen, Alexion, Agilent, Waters Co and others.

Biopharmaceuticals are therapeutic agents intended to treat symptoms and/or underlying causes of a variety of disorders and diseases. They have been a growing part of the pharmaceutical landscape since the early 1980s and is, today, one of the fastest growing areas in the pharmaceutical industry, growing at an average rate of 12%-15% over the past two years. Today, there are many biologics in the approval pipeline and it has been projected that over 65% of drugs approved for the marketplace in 2017 will be the result of biotechnology. Biopharmaceuticals hold great promise for treating some of the most intractable medical conditions such as cancer and autoimmune disease.

Biotechnology

Biotechnology is the applied knowledge of biology, it seeks to duplicate or change the function of a living cell, so it will work in a more predictable and controllable way. The biotechnology industry uses advances in genetics research to develop products for human diseases and conditions.

Biotech opportunities largely mirror those in the pharmaceutical industry. The key difference is that biotech firms are much more focused on research because they are still developing their initial products. Biotech firms tend to expand their marketing and sales forces when and if a viable product nears FDA approval.

Biopharmaceutical and Biotechnology Company Profiles

50 Key Biopharmaceutical and Biotechnology Companies profiles these market leaders in-depth, presenting detailed information about each company, including:
  • a Corporate Summary
  • Selected Biopharmaceutical Products
  • Biopharmaceuticals in Development
  • Selected Corporate Developments
  • Company Financials
  • Regional Revenue Breakdown by Percentage (%)

Companies Profiled Include:

  • AbbVie
  • Agilent Technologies Inc.
  • Alexion Pharmaceuticals Inc
  • Allergan plc
  • Ambry Genetics
  • Amgen, Inc
  • AstraZeneca plc
  • Bayer AG
  • Berry Genomics Co Ltd.
  • Biogen
  • BioMarin Pharmaceutical Inc
  • Bristol Myers Squibb
  • Celgene
  • CRISPR Therapeutics AG
  • CSL Behring
  • Dr. Reddy’s Laboratories Limited
  • Eli Lilly & Co
  • Enzo Biochem, Inc
  • Evotec AG
  • Exelixis
  • Genmab
  • Gilead Sciences
  • GlaxoSmithKline
  • Grifols International S.A.
  • Guardant Health
  • Illumina
  • Incyte Corporation
  • Johnson & Johnson
  • Merck & Co, Inc.
  • Mylan
  • Myriad Genetics
  • Novartis International AG
  • Novo Nordisk A/S
  • Organogenesis
  • Oxford Nanopore Technologies
  • Perkin Elmer, Inc
  • Pfizer
  • Precision BioSciences Inc
  • QIAGEN N.V.
  • Regeneron Pharmaceuticals
  • Roche Ltd.
  • Sanofi
  • Seattle Genetics, Inc
  • Shire
  • Takeda
  • Teva Pharmaceutical Industries, Ltd.
  • Thermo Fisher Scientific, Inc
  • UCB S.A.
  • United Therapeutics Corporation
  • Waters Corporation
  • Executive Summary
    • Introduction
    • Scope and Methodology
    • Market Summary
      • Table Summary: Top 10 of the Top 50 Biotechnology Companies by Biologic Revenues 2017 ($ billions)
  • Introduction
    • Biopharmaceuticals and Biotherapeutics
      • Biopharmaceuticals
      • Biotechnology
      • Areas of Treatment for Biopharmaceuticals
    • Regulations for Biopharmaceuticals
  • 50 Key Biopharmaceutical and Biotechnology Companies: Profiles
    • AbbVie
      • Table AbbVie Corporate Summary
      • Company Overview
        • Table Selected AbbVie Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table AbbVie (2015-2017) ($ millions)
    • Agilent Technologies Inc.
      • Table Agilent Corporate Summary
      • Company Overview
        • Table Agilent Regional Breakdown by %
      • Company Financials
        • Table Agilent (2015-2017) ($ millions)
    • Alexion Pharmaceuticals Inc
      • Table Alexion Corporate Summary
      • Company Overview
        • Table Alexion Regional Breakdown by %
        • Table Selected Alexion Biopharmaceutical Products
        • Table Selected Alexion Biopharmaceuticals in Development
      • Company Financials
        • Table Alexion (2015-2017) ($ millions)
    • Allergan plc
      • Table Allergan Corporate Summary
      • Company Overview
        • Table Selected Corporate Developments
      • Company Financials
        • Table Allergan (2015-2017) ($ millions)
    • Ambry Genetics
      • Table Ambry Genetics Corporate Summary
      • Company Overview
    • Amgen, Inc
      • Table Amgen Corporate Summary
      • Company Overview
        • Table Amgen Regional Breakdown by %
        • Table Selected Biopharmaceutical Products
        • Table Selected Amgen Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table Amgen (2015-2017) ($ millions)
    • AstraZeneca plc
      • Table AstraZeneca Corporate Summary
      • Company Overview
        • Table AstraZeneca Regional Breakdown by %
        • Table Selected Biopharmaceuticals Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table AstraZeneca (2015-2017) ($ millions)
    • Bayer AG
      • Table Bayer AG Corporate Summary
      • Company Overview
        • Table Bayer Regional Breakdown by %
        • Table Selected Bayer AG Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table Bayer (2015-2017) ($ millions)
    • Berry Genomics Co Ltd.
      • Table Berry Genomics Corporate Summary
      • Company Overview
    • Biogen
      • Table Biogen Corporate Summary
      • Company Overview
        • Table Biogen Regional Breakdown by %
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table Biogen (2015-2017) ($ millions)
    • BioMarin Pharmaceutical Inc
      • Table BioMarin Pharmaceutical Corporate Summary
      • Company Overview
        • Table BioMarin Regional Breakdown by %
        • Table Selected Biopharmaceuticals Products
        • Table Selected Biopharmaceuticals in Development
      • Company Financials
        • Table BioMarin (2014-2017) ($ millions)
    • Bristol Myers Squibb
      • Table Bristol Myers Squibb Corporate Summary
      • Company Overview
        • Table BMS Regional Breakdown by %
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table BMS (2015-2017) ($ millions)
    • Celgene
      • Table Celgene Corporate Summary
      • Company Overview
        • Table Celgene Regional Breakdown by %
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table Celgene (2015-2017) ($ millions)
    • CRISPR Therapeutics AG
      • Table CRISPR Therapeutics Corporate Summary
      • Company Overview
        • Table Selected Corporate Developments
      • Company Financials
        • Table CRISPR (2015-2017) ($ thousand)
    • CSL Behring
      • Table CSL Behring Corporate Summary
      • Company Overview
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
      • Company Financials
        • Table CSL Behring (2015-2017) ($ millions)
    • Dr. Reddy's Laboratories Limited
      • Table Dr Reddy's Laboratories Corporate Summary
      • Company Overview
      • Company Financials
        • Table Dr Reddy's Laboratories (2015-2017) ($ millions)
    • Eli Lilly & Co
      • Table Eli Lilly Corporate Summary
      • Company Overview
        • Table Eli Lilly Regional Breakdown %
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table Eli Lilly (2015-2017) ($ millions)
    • Enzo Biochem, Inc
      • Table Enzo Biochem Corporate Summary
      • Company Overview
      • Company Financials
        • Table Enzo Biochem (2014-2017) ($ thousands)
    • Evotec AG
      • Table Evotec AG Corporate Summary
      • Company Overview
        • Table Evotec Regional Breakdown by %
        • Table Selected Corporate Developments
      • Company Financials
        • Table Evotec (2015-2017) ($ Thousands)
    • Exelixis
      • Table Exelixis Corporate Summary
      • Company Overview
        • Table Exelixis Regional Breakdown by %
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table Exelixis (2015-2017) ($ thousands)
    • Genmab
      • Table Genmab Corporate Summary
      • Company Overview
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table Genmab (2015-2017) ($ thousands)
    • Gilead Sciences
      • Table Gilead Sciences Corporate Summary
      • Company Overview
        • Table Gilead Sciences Regional Breakdown by %
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table Gilead (2015-2017) ($ millions)
    • GlaxoSmithKline
      • Table GlaxoSmithKline Corporate Summary
      • Company Overview
        • Table GSK Regional Breakdown by %
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table GSK (2015-2017) ($ millions)
    • Grifols International S.A.
      • Table Grifols International S.A. Corporate Summary
      • Company Overview
        • Table Grifols Regional Breakdown by %
        • Table Selected Biopharmaceutical Products
        • Table Selected Corporate Development
      • Company Financials
        • Table Grifols (2015-2017) ($ millions)
    • Guardant Health
      • Table Guardant Health Corporate Summary
      • Company Overview
    • llumina
      • Table Illumina Corporate Summary
      • Company Overview
      • Company Financials
        • Table Illumina (2015-2017) ($ millions)
    • Incyte Corporation
      • Table Incyte Corporate Summary
      • Company Overview
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Development
      • Company Financials
        • Table Incyte (2015-2017) ($ millions)
    • Johnson & Johnson
      • Table Johnson & Johnson Corporate Summary
      • Company Overview
        • Table J&J Regional Breakdown by %
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table J&J (2015-2017) ($ millions)
    • Merck & Co, Inc.
      • Table Merck Corporate Summary
      • Company Overview
        • Table Merck Regional Breakdown by %
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table Merck (2015-2017) ($ millions)
    • Mylan
      • Table Mylan Corporate Summary
      • Company Overview
        • Table Mylan Regional Breakdown by %
      • Company Financials
        • Table Mylan (2015-2017) ($ millions)
    • Myriad Genetics
      • Table Myriad Genetics Corporate Summary
      • Company Overview
        • Table Selected Corporate Developments
      • Company Financials
        • Table Myriad (2015-2017) ($ millions)
    • Novartis International AG
      • Table Novartis Corporate Summary
      • Company Overview
        • Table Novartis Regional Breakdown by %
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table Novartis (2015-2017) ($ millions)
    • Novo Nordisk A/S
      • Table Novo Nordisk Corporate Summary
      • Company Overview
        • Table Novo Nordisk Regional Breakdown by %
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
      • Company Financials
        • Table Novo Nordisk (2015-2017) ($ millions)
    • Organogenesis
      • Table Organogenesis Corporate Summary
      • Company Overview
    • Oxford Nanopore Technologies
      • Table Oxford Nanopore Technologies Corporate Summary
      • Company Overview
    • Perkin Elmer, Inc
      • Table Perkin Elmer Corporate Summary
      • Company Overview
        • Table Selected Corporate Developments
      • Company Financials
        • Table PerkinElmer (2015-2017) ($ millions)
    • Pfizer
      • Table Pfizer Corporate Summary
      • Company Overview
        • Table Pfizer Regional Breakdown by %
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table Pfizer (2015-2017) ($ millions)
    • Precision BioSciences Inc
      • Table Precision BioSciences Corporate Summary
      • Company Overview
    • QIAGEN N.V.
      • Table QIAGEN Corporate Summary
      • Company Overview
        • Table QIAGEN Regional Breakdown by %
        • Table Selected Corporate Developments
      • Company Financials
        • Table QIAGEN (2015-2017) ($ millions)
    • Regeneron Pharmaceuticals
      • Table Regeneron Corporate Summary
      • Company Overview
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table Regeneron (2015-2017) ($ millions)
    • Roche Ltd.
      • Table Roche Corporate Summary
      • Company Overview
        • Table Roche Regional Breakdown by %
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
      • Company Financials
        • Table Roche (2015-2017) ($ millions)
    • Sanofi
      • Table Sanofi Corporate Summary
      • Company Overview
        • Table Sanofi Regional Breakdown by %
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table Sanofi (2015-2017) ($ millions)
    • Seattle Genetics, Inc
      • Table Seattle Genetics Corporate Summary
      • Company Overview
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table Seattle Genetics (2015-2017) ($ millions)
    • Shire
      • Table Shire Corporate Summary
      • Company Overview
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Development
      • Company Financials
        • Table Shire (2015-2017) ($ millions)
    • Takeda
      • Table Takeda Corporate Summary
      • Company Overview
        • Table Takeda Regional Breakdown by %
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table Takeda (2015-2017) ($ millions)
    • Teva Pharmaceutical Industries, Ltd.
      • Table Teva Corporate Summary
      • Company Overview
        • Table Teva Regional Breakdown by %
        • Table Selected Biopharmaceutical Products
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table Teva (2015-2017) ($ millions)
    • Thermo Fisher Scientific, Inc
      • Table Thermo Fisher Scientific Corporate Summary
      • Company Overview
        • Table Selected Corporate Developments
      • Company Financials
        • Table Thermo Fisher Scientific (2015-2017) ($ millions)
    • UCB S.A.
      • Table UCB Corporate Summary
      • Company Overview
        • Table Selected Biopharmaceuticals in Development
        • Table Selected Corporate Developments
      • Company Financials
        • Table UCB (2015-2017) ($ millions)
    • United Therapeutics Corporation
      • Table United Therapeutics Corporate Summary
      • Company Overview
        • Table Selected Biopharmaceuticals in Development
      • Company Financials
        • Table United Therapeutics (2015-2017) ($ millions)
    • Waters Corporation
      • Table Waters Corporate Summary
      • Company Overview
        • Table Waters Regional Breakdown by %
      • Company Financials
        • Table Waters (2015-2017) ($ millions)

In this report, {{keyword[keywordTextProperty]}} appears {{keyword[keywordCountProperty]}} times. {{searchResults.STATRESULT.SUMMARY.KW[keywordTextProperty]}} appears {{searchResults.STATRESULT.SUMMARY.KW[keywordCountProperty]}} times.

We were unable to search inside this report.
No results matched your search criteria.

Search for an exact word or phrase by placing the word or phrase in quotation marks ("market trend"). Search for different versions or tenses of a word by placing an asterisk at the end of the word (pharma*).

Please note that your term must be at least three characters long and numbers will be blocked by the # sign.